Challenges and Opportunities for In Vivo PROTAC Delivery

体内 医学 雄激素受体 前列腺癌 药理学 图书馆学 计算机科学 癌症 内科学 生物 遗传学
作者
Andrew B. Benowitz,Paul Scott‐Stevens,John D. Harling
出处
期刊:Future Medicinal Chemistry [Future Science Ltd]
卷期号:14 (3): 119-121 被引量:20
标识
DOI:10.4155/fmc-2021-0223
摘要

Future Medicinal ChemistryVol. 14, No. 3 EditorialChallenges and opportunities for in vivo PROTAC deliveryAndrew B Benowitz, Paul T Scott-Stevens & John D HarlingAndrew B Benowitz *Author for correspondence: E-mail Address: andrew.b.benowitz@GSK.comhttps://orcid.org/0000-0002-9913-605XMedicine Design, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK, Paul T Scott-StevensIn Vitro/In Vivo Translation, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK & John D HarlingMedicine Design, GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UKPublished Online:16 Sep 2021https://doi.org/10.4155/fmc-2021-0223AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: chameleonicityoral exposureparenteral deliveryPROTACReferences1. Nalawansha DA, Crews CM. PROTACs: an emerging therapeutic modality in precision medicine. Cell Chem. Biol. 27(8), 998–1014 (2020).Crossref, Medline, CAS, Google Scholar2. Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45(12), 2615–2623 (2002).Crossref, Medline, CAS, Google Scholar3. Lee GT, Nagaya N, Desantis J et al. Effects of MTX-23, a novel PROTAC of androgen receptor splice variant-7 and androgen receptor, on CRPC resistant to second-line antiandrogen therapy. Mol. Cancer Ther. 20(3), 490–499 (2021).Crossref, Medline, CAS, Google Scholar4. Luo G, Li Z, Lin X et al. Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo. Acta Pharm. Sin. B 11(5), 1300–1314 (2021).Crossref, Medline, CAS, Google Scholar5. Whitty A, Zhong M, Viarengo L, Beglov D, Hall DR, Vajda S. Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs. Drug Discov. Today 21(5), 712–717 (2016).Crossref, Medline, CAS, Google Scholar6. Atilaw Y, Poongavanam V, Svensson Nilsson C et al. Solution conformations shed light on PROTAC cell permeability. ACS Med. Chem. Lett. 12(1), 107–114 (2021).Crossref, Medline, CAS, Google Scholar7. David L, Wenlock M, Barton P, Ritzén A. Prediction of chameleonic efficiency. ChemMedChem 16(17), 2669–2685 (2021).Crossref, Medline, CAS, Google Scholar8. Ermondi G, Garcia Jimenez D, Rossi Sebastiano M, Caron G. Rational control of molecular properties is mandatory to exploit the potential of PROTACs as oral drugs. ACS Med. Chem. Lett. 12(7), 1056–1060 (2021).Crossref, Medline, CAS, Google Scholar9. Hodge D, Back DJ, Gibbons S, Khoo SH, Marzolini C. Pharmacokinetics and drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine. Clin. Pharmacokinet. 60(7), 835–853 (2021).Crossref, Medline, CAS, Google Scholar10. Miah AH, Smith IED, Rackham M et al. Optimization of a series of RIP2 PROTACs. J. Med. Chem. 64(17), 12978–13003 (2021).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited BySpecial Focus Issue – Targeted protein degradation: a new paradigm in medicinal chemistryHarriet Wall26 January 2022 | Future Medicinal Chemistry, Vol. 14, No. 3 Vol. 14, No. 3 Follow us on social media for the latest updates Metrics Downloaded 913 times History Received 2 August 2021 Accepted 1 September 2021 Published online 16 September 2021 Published in print February 2022 Information© 2021 Newlands PressKeywordschameleonicityoral exposureparenteral deliveryPROTACFinancial & competing interests disclosureThe authors are employees and/or shareholders of GlaxoSmithKline. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被念安采纳,获得20
1秒前
赘婿的应助被阿吉采纳,获得10
2秒前
FashionBoy的应助被自由笙采纳,获得10
2秒前
2秒前
白江虎发布了新的文献求助10
2秒前
2秒前
隐形曼青的应助被小SCI采纳,获得10
3秒前
风吹麦浪的应助被elysia采纳,获得10
3秒前
4秒前
大模型的应助被季喃采纳,获得10
4秒前
momo完成签到,获得积分10
4秒前
5秒前
5秒前
5秒前
大粥完成签到 ,获得积分10
6秒前
6秒前
6秒前
gamerks发布了新的文献求助10
7秒前
7秒前
lli发布了新的文献求助30
7秒前
庚辛完成签到,获得积分10
8秒前
8秒前
xc完成签到,获得积分10
8秒前
9秒前
爱科研的赛关注了科研通微信公众号
9秒前
9秒前
烟花的应助被丰富的柠檬采纳,获得10
10秒前
10秒前
10秒前
10秒前
Brian发布了新的文献求助10
10秒前
重要的忆雪的应助被沉默笑蓝采纳,获得30
10秒前
克克发布了新的文献求助10
11秒前
sheryy发布了新的文献求助30
11秒前
xioabu完成签到,获得积分10
11秒前
小陈呀发布了新的文献求助10
12秒前
牧百川发布了新的文献求助10
12秒前
xc发布了新的文献求助10
12秒前
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183730
求助须知:如何正确求助?哪些是违规求助? 9572975
关于积分的说明 21828453
捐赠科研通 7780887
什么是DOI,文献DOI怎么找? 3434086
关于科研通互助平台的介绍 2558276
邀请新用户注册赠送积分活动 2480557